SCHEMBL27051007

SCHEMBL27051007

Bc1c(C)c(C)cc(F)c1OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27050961 0.77 — —
SCHEMBL13087959 0.75 — —
SCHEMBL13488479 0.72 SLC6A2 (0.32) —
SCHEMBL13376481 0.72 KDM4E (0.31) —
SCHEMBL11916153 0.70 RAPGEF4 (0.30) —
SCHEMBL16334835 0.69 LMNA (0.33) —
SCHEMBL18726947 0.69 CXCR5 (0.32) —
SCHEMBL11962257 0.68 ACHE (0.52) —
SCHEMBL12517837 0.68 FFAR4 (0.41) —
SCHEMBL20624746 0.67 GAA (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024497-A1 METHODS FOR THE SYNTHESIS OF PROTEIN-DRUG CONJUGATES CIDARA THERAPEUTICS, INC. 2024-01-25 — — US disclosed
Send feedback